D-1053-2020 Class II Terminated
FDA drug recall D-1053-2020 was initiated by Matthew 7:25 Inc Dba Thrive Pharmacy on Mar 10, 2020 and is designated Class II. Reason for recall: Subpotent Drug The recall status is terminated (terminated Jun 2, 2023). Affected quantity: 403 troches.
Recall Details
- Product Type
- Drugs
- Report Date
- Apr 1, 2020
- Initiation Date
- Mar 10, 2020
- Termination Date
- Jun 2, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 403 troches
Product Description
Buprenorphine Watermelon 8 mg Troche, supplied in plastic troche molds with cardboard outer sleeve, Thrive Pharmacy 2863 St Johns Bluff RD. South # 135 Jacksonville, Florida
Reason for Recall
Subpotent Drug
Distribution Pattern
Florida
Code Information
Lot: 191203F Exp. 05/31/2020
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1053-2020
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026